Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.74B
-
Number of holders
-
1582
-
Total 13F shares, excl. options
-
1.27B
-
Shares change
-
+10.8M
-
Total reported value, excl. options
-
$67.9B
-
Value change
-
+$611M
-
Put/Call ratio
-
0.76
-
Number of buys
-
605
-
Number of sells
-
-766
-
Price
-
$53.36
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q3 2017
1,703 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q3 2017.
ABBOTT LABORATORIES - Common Stock (ABT) has 1,582 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.27B shares
of 1.74B outstanding shares and own 73.12% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (132M shares), BlackRock Inc. (107M shares), STATE STREET CORP (73.1M shares), Capital Research Global Investors (67.9M shares), WELLINGTON MANAGEMENT GROUP LLP (51.2M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (49.2M shares), Bank of New York Mellon Corp (32.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (27.6M shares), NORTHERN TRUST CORP (27.3M shares), and BANK OF AMERICA CORP /DE/ (22.9M shares).
This table shows the top 1582 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.